| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
32,936 |
30,047 |
$8.01M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
30,237 |
28,376 |
$5.80M |
| A0425 |
Ground mileage, per statute mile |
37,223 |
25,697 |
$2.37M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,249 |
7,325 |
$1.78M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
14,418 |
12,151 |
$1.35M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
8,305 |
6,991 |
$713K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,924 |
5,574 |
$635K |
| 59025 |
Fetal non-stress test |
4,979 |
2,633 |
$427K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,577 |
3,398 |
$424K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
11,760 |
7,676 |
$359K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,682 |
1,478 |
$258K |
| G0378 |
Hospital observation service, per hour |
1,002 |
862 |
$220K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,403 |
1,419 |
$178K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,128 |
1,097 |
$173K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
15,487 |
13,972 |
$162K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
39,649 |
35,777 |
$142K |
| 64493 |
|
419 |
376 |
$132K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
449 |
324 |
$128K |
| 80053 |
Comprehensive metabolic panel |
43,125 |
38,727 |
$110K |
| 43235 |
|
608 |
513 |
$87K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,401 |
487 |
$67K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
983 |
927 |
$66K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,004 |
7,897 |
$65K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
351 |
323 |
$56K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,591 |
1,456 |
$46K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
12,291 |
5,947 |
$44K |
| 43450 |
|
561 |
476 |
$43K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
128 |
117 |
$43K |
| 64495 |
|
459 |
368 |
$36K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,439 |
9,538 |
$32K |
| 64494 |
|
472 |
374 |
$32K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
97 |
90 |
$32K |
| 84484 |
|
3,444 |
2,419 |
$31K |
| 87631 |
|
600 |
567 |
$30K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,723 |
1,407 |
$30K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,703 |
6,016 |
$27K |
| 97597 |
|
1,358 |
647 |
$27K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,396 |
1,233 |
$23K |
| 71250 |
|
670 |
568 |
$23K |
| 96367 |
|
795 |
317 |
$19K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
333 |
311 |
$19K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
68 |
59 |
$17K |
| 82803 |
|
1,990 |
1,682 |
$17K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,740 |
4,741 |
$17K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,497 |
4,069 |
$16K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
70 |
66 |
$16K |
| 83690 |
|
3,872 |
3,554 |
$14K |
| 77334 |
|
98 |
39 |
$14K |
| 77336 |
|
615 |
197 |
$14K |
| 71046 |
Radiologic examination, chest; 2 views |
3,129 |
2,913 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
7,421 |
6,647 |
$13K |
| 87428 |
|
270 |
249 |
$12K |
| 83605 |
|
2,215 |
1,903 |
$10K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
30 |
26 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,854 |
1,670 |
$9K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
224 |
63 |
$8K |
| A0433 |
Advanced life support, level 2 (als 2) |
42 |
41 |
$7K |
| 87430 |
|
1,237 |
1,165 |
$7K |
| 77300 |
|
106 |
73 |
$7K |
| 95816 |
|
85 |
72 |
$6K |
| 81003 |
|
11,857 |
10,702 |
$6K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
51 |
48 |
$5K |
| 81001 |
|
7,268 |
6,723 |
$5K |
| 70450 |
Computed tomography, head or brain; without contrast material |
177 |
154 |
$4K |
| 76830 |
Ultrasound, transvaginal |
71 |
68 |
$4K |
| 87081 |
|
952 |
892 |
$4K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
28 |
27 |
$4K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
13 |
$3K |
| 81025 |
|
1,229 |
1,160 |
$3K |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
46 |
37 |
$2K |
| 73130 |
|
144 |
70 |
$2K |
| 97803 |
|
48 |
46 |
$2K |
| 95819 |
|
27 |
25 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
50 |
50 |
$1K |
| 82550 |
|
476 |
438 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
54 |
49 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
14 |
13 |
$745.87 |
| 83735 |
|
366 |
319 |
$740.46 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
16 |
16 |
$667.03 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$570.41 |
| 85027 |
|
301 |
231 |
$485.21 |
| 36415 |
Collection of venous blood by venipuncture |
1,228 |
808 |
$444.00 |
| 86900 |
|
92 |
65 |
$408.27 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
43 |
42 |
$402.93 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
142 |
106 |
$387.25 |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
15 |
14 |
$368.52 |
| 74018 |
|
13 |
12 |
$216.09 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
249 |
195 |
$198.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
442 |
264 |
$194.25 |
| 85007 |
|
137 |
123 |
$157.71 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,511 |
1,273 |
$153.04 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
25 |
25 |
$146.93 |
| 85610 |
|
96 |
87 |
$119.22 |
| 87807 |
|
26 |
26 |
$103.37 |
| 86850 |
|
92 |
65 |
$89.55 |
| 87420 |
|
13 |
13 |
$76.62 |
| 94760 |
|
167 |
78 |
$70.62 |
| 80069 |
|
141 |
83 |
$68.44 |
| 80061 |
Lipid panel |
43 |
42 |
$58.48 |
| 84145 |
|
13 |
13 |
$57.70 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
201 |
171 |
$52.18 |
| 86901 |
|
92 |
65 |
$43.59 |
| 84703 |
|
14 |
13 |
$37.42 |
| 74022 |
|
13 |
12 |
$26.78 |
| 87077 |
|
12 |
12 |
$23.20 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,844 |
4,402 |
$0.98 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,132 |
1,039 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
154 |
140 |
$0.00 |
| 88312 |
|
12 |
12 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
22 |
16 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
16 |
13 |
$0.00 |
| 76937 |
|
13 |
12 |
$0.00 |
| 87186 |
|
15 |
14 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
418 |
369 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
13 |
$0.00 |
| A9270 |
Non-covered item or service |
587 |
204 |
$0.00 |
| 86140 |
|
33 |
27 |
$0.00 |
| C1769 |
Guide wire |
32 |
26 |
$0.00 |
| 88304 |
|
26 |
24 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
49 |
48 |
$0.00 |
| 87088 |
|
15 |
14 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
16 |
12 |
$0.00 |
| 83615 |
|
13 |
12 |
$0.00 |